Early proactive management improves upper urinary tract function and reduces the need for surgery in patients with myelomeningocele

Neurourology and Urodynamics

Volumn 25, Issue 7, 2006, Pages 758-762

  Kessler, Thomas M ^a   Lackner, Jakob ^a   Kiss, Gustav ^a   Rehder, Peter ^a   Madersbacher, Helmut ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

Myelomeningocele; Proactive management; Surgery; Upper urinary tract function

Indexed keywords

ANTIREFLUX OPERATION; ARTICLE; BLADDER SURGERY; CONSERVATIVE TREATMENT; CONTROLLED STUDY; EVALUATION; FOLLOW UP; HUMAN; INFANT; MAJOR CLINICAL STUDY; MENINGOMYELOCELE; NEWBORN; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCHOOL CHILD; SPHINCTEROTOMY; TRANSURETHRAL RESECTION; UNINEPHRECTOMY; URINARY TRACT DISEASE; URINARY TRACT FUNCTION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; MALE; MENINGOMYELOCELE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; URINARY TRACT PHYSIOLOGY; UROLOGIC DISEASES;

EID: 33750625265     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.20304     Document Type: Article

References (24)

1. Abrams P, Cardozo L, Fall M, et al. 2002.The standardisation of terminology of lower urinary tract function: Report from the Standardisation Sub-Committee of the International Continence Society. Neurourol Urodyn 21:167-78.
2. Bauer SB. 2003. The management of the myelodysplastic child: A paradigm shift. BJU Int 92:23-8.
3. Bauer SB, Hallett M, Khoshbin S, et al. 1984. Predictive value of urodynamic evaluation in newborns with myelodysplasia. JAMA 252:650-2.
4. Edelstein RA, Bauer SB, Kelly MD, et al. 1995. The long-term urological response of neonates with myelodysplasia treated proactively with intermittent catheterization and anticholinergic therapy. J Urol 154:1500-4.
5. Galloway NT, Mekras JA, Helms M, et al. 1991. An objective score to predict upper tract deterioration in myelodysplasia. J Urol 145:535-7.
6. Geraniotis E, Koff SA, Enrile B. 1988. The prophylactic use of clean intermittent catheterization in the treatment of infants and young children with myelomeningocele and neurogenic bladder dysfunction. J Urol 139:85-6.
7. Hopps CV, Kropp KA. 2003. Preservation of renal function in children with myelomeningocele managed with basic newborn evaluation and close followup. J Urol 169:305-8.
8. Kasabian NG, Bauer SB, Dyro FM, et al. 1992. The prophylactic value of clean intermittent catheterization and anticholinergic medication in newborns and infants with myelodysplasia at risk of developing urinary tract deterioration. Am J Dis Child 146:840-3.
9. Kessler TM, Lackner J, Kiss G, et al. 2006. Predictive value of initial urodynamic pattern on urinary continence in patients with myelomeningocele. Neurourol Neurodyn [2006 May 23, epub ahead of print].
10. Klose AG, Sackett CK, Mesrobian HG. 1990, Management of children with myelodysplasia: Urological alternatives. J Urol 144:1446-49.
11. Kobayashi S, Shinno Y, Kakizaki H, et al. 1992. Relevance of detrusor hyperreflexia, vesical compliance and urethral pressure to the occurrence of vesicoureteral reflux in myelodysplastic patients. J Urol 147:413-5.
12. Kurzrock EA, Polse S, 1998. Renal deterioration in myelodysplastic children: Urodynamic evaluation and clinical correlates. J Urol 159:1657-61.
13. Lais A, Kasabian NG, Dyro FM, et al. 1993. The neurosurgical implications of continuous neurourological surveillance of children with myelodysplasia. J Urol 150:1879-83.
14. Müller T, Arbeiter K, Aufricht C. 2002. Renal function in meningomyelocele: Risk factors, chronic renal failure, renal replacement therapy and transplantation. Curr Opin Urol 12:479-84.
15. Madersbacher H. 1975. Development of the upper urinary tract in myelomeningocele and consequent urological care. Int Urol Nephrol 7:13-22.
16. Madersbacher H. 2004. Intravesical electrical stimulation of the bladder. In: Corcos J, Schick E, editors. Textbook of the neurogenic bladder. London & New York: Martin Dunitz. pp 551-5.
17. McGuire EJ, Woodside JR, Borden TA, et al. 1981. Prognostic value of urodynamic testing in myelodysplastic patients. J Urol 126:205-9.
18. Perez LM, Khoury J, Webster GD. 1992. The value of urodynamic studies in infants less than 1 year old with congenital spinal dysraphism. J Urol 148:584-7.
19. Schäfer W, Abrams P, Liao L, et al. 2002. Good urodynamic practices: Uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn 21:261-74.
20. Tanaka H, Kakizaki H, Kobayashi S, et al. 1999. The relevance of urethral resistance in children with myelodysplasia: Its impact on upper urinary tract deterioration and the outcome of conservative management. J Urol 161:929-32.
21. Tarcan T, Bauer S, Olmedo E, et al. 2001. Long-term followup of newborns with myelodysplasia and normal urodynamic findings: Is follow up necessary? J Urol 165:564-7.
22. Teichman JM, Scherz HC, Kim KD, et al. 1994. An alternative approach to myelodysplasia management: Aggressive observation and prompt intervention. J Urol 152:807-11.
23. Wennerstrom M, Hansson S, Jodal U, et al. 2000. Primary and acquired renal scarring in boys and girls with urinary tracf infection. J Pediatr 136:30-4.
24. Wu HY, Baskin LS, Kogan BA. 1997. Neurogenic bladder dysfunction due to myelomeningocele: Neonatal versus childhood treatment. J Urol 157:2295-7.